Bio-Path Holdings Company Culture

Bio-Path Holdings Culture

This score is derived from employee ratings & reviews

N/A

Rate Your Company

Top Rated Culture Dimensions

Share Your Opinion

Anonymously Rate Your Experience & Make Work Better

Bio-Path Holdings CEO

Peter Nielsen

Rate Your CEO

Bio-Path Holdings Company Information

Bio-Path Holdings Company Overview

Bio-Path Holdings is a biotechnology company developing therapeutic products for the liposomal delivery of nucleic acids in cancer patients.

Headquarter	2626 South Loop, Suite 180 Houston, TX United States of America
Website	www.biopathholdings.com
Founding Date	2011
Tel	(832)971-6616
Company Status	Public
Stock	BPTH

Bio-Path Holdings Competitors

Bio-Path Holdings competitors include Corcept Therapeutics and Acceleron Pharma. See below how Bio-Path Holdings compares to its competitors with CEO Rankings, Product & Services, NPS, Pricing, Customer Services, Overall Culture Score, eNPS, Gender and Diversity Scores.

Bio-Path Holdings CEO & Leadership

Bio-Path Holdings CEO - Peter Nielsen

Rate Your CEO

Bio-Path Holdings Leadership

Bio-Path Holdings Careers

Bio-Path Holdings Jobs

No Recent Jobs found for Bio-Path Holdings on Comparably

Mark that you are interested and we will alert you when there are new positions available listed on Comparably

Let Bio-Path Holdings Know You Want To Work There

Frequently Asked Questions regarding Bio-Path Holdings

What is Bio-Path Holdings address?

Bio-Path Holdings location is at 2626 South Loop, Suite 180

What is Bio-Path Holdings revenue?

Bio-Path Holdings revenue is $37k

Who are Bio-Path Holdings competitors?

Bio-Path Holdings main competitors are Corcept Therapeutics, Acceleron Pharma

Who is Bio-Path Holdings leadership?

Douglas Morris are part of Bio-Path Holdings leadership, Peter Nielsen is the CEO

Rate your company